Interestingly, IRF-1 could reverse the multiple drug resistance of gastric cancer by decreasing the expression of P-glycoprotein [23], and high expression of IRF-1 contributes to 5-fluorouracil chemosensitivity in gastric cancer cells [24]. The gene discussed is IRF1; the disease is gastric cancer.